Abstract
Sera from 13 patients with initial complement fixation (CF) titres of 160 or above, and from 5 with rising titres to Mycoplasma pneumoniae were tested at 2-monthly intervals for CF antibodies and for cold agglutinins. In an attempt to differentiate between ‘early’ and ‘late’ sera with raised titres, initial sera and those, taken 6 to 8 months later, with a CF titre of 160 or above were tested by the metabolic inhibition test and also treated with 2-mercaptoethanol (2ME).
Cold agglutinins were detected in 5 of the 13 initial sera but in none of the 7 ‘late’ sera with raised CF titres. A 4-fold or greater fall in the CF titre after treatment with 2ME occurred in 5 of the 12 initial sera tested, and in one of the 7 ‘late’ sera. Metabolic inhibiting antibodies were present in 7 of the 12 initial sera and in 4 of the 6 ‘late’ sera tested. In only one patient with a raised initial CF titre but no cold agglutinins and no 2ME effect was there later evidence of a current infection with M. pneumoniae. Cold agglutinins were present and/or there was a 2ME effect in the initial sera from all 5 patients with rising titres.
It is concluded that a combination of cold agglutinins and the effect of 2ME on the CF titres will help to differentiate ‘early’ from ‘late’ sera with significantly raised CF antibodies.
Get full access to this article
View all access options for this article.